{
    "clinical_study": {
        "@rank": "142995", 
        "arm_group": [
            {
                "arm_group_label": "Healthy Volunteers", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Obese, Otherwise Healthy Volunteers", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of\n      a predefined dose range of co-administered Baclofen and Memantine in non-obese (Part A) and\n      obese (Part B), otherwise healthy subjects."
        }, 
        "brief_title": "A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults", 
        "condition": [
            "Healthy Volunteers;", 
            "Obese, Otherwise Healthy Volunteers"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Adult males or females aged 18 to 45 years inclusive;\n\n          2. Subjects with body mass index:\n\n             For Part A: \u226518 kg/m\u00b2 and \u226425 kg/m\u00b2; For Part B: \u226533 kg/m\u00b2 and \u226440 kg/m\u00b2.\n\n          3. Subjects with a total body weight of \u226550 kg (Part A and Part B);\n\n          4. Subjects who are healthy as determined by the Investigator based on pre study medical\n             history, physical examination, vital signs (blood pressure, pulse rate, respiratory\n             rate and body temperature) and 12-lead ECG at screening and each admission;\n\n          5. Subjects whose clinical laboratory test results are not clinically relevant and are\n             acceptable to the Investigator at screening and each admission;\n\n          6. Aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and\n             bilirubin \u22641.5 x upper limit of normal (ULN);\n\n          7. Subjects who are negative for hepatitis B surface antigen (HBsAg), hepatitis C\n             antibody and human immunodeficiency virus (HIV) I and II tests at screening;\n\n          8. Subjects who are negative for drugs of abuse and alcohol tests at screening and each\n             admission;\n\n          9. Subjects who are non-smokers or who have not smoked or used nicotine-containing\n             products for at least 3 months prior to screening;\n\n         10. Subjects with an estimated creatinine clearance \u2265100 mL/minute for male subjects or\n\n             \u226590 mL/minute for female subjects (Cockcroft-Gault method) at screening;\n\n         11. Subjects who are able and willing to give written informed consent."
            }, 
            "gender": "Both", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02001584", 
            "org_study_id": "RGH-917-001"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Healthy Volunteers", 
                    "Obese, Otherwise Healthy Volunteers"
                ], 
                "intervention_name": "Baclofen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Healthy Volunteers", 
                    "Obese, Otherwise Healthy Volunteers"
                ], 
                "intervention_name": "Memantine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Obese, Otherwise Healthy Volunteers", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Baclofen", 
                "Memantine"
            ]
        }, 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "Volunteers@Quintiles.co.uk", 
                "last_name": "Sajeed Ali", 
                "phone": "00 44 800 634 1122"
            }, 
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom"
                }, 
                "name": "Quintiles Drug Research Unit at Guy's Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Safety and tolerability of co-administered baclofen and memantine via C-SSRS", 
                "time_frame": "From Baseline until Follow-up"
            }, 
            {
                "measure": "Safety and tolerability of co-administered baclofen and memantine via Adverse Events", 
                "time_frame": "From Baseline until Follow-up"
            }, 
            {
                "measure": "Safety and tolerability of co-administered baclofen and memantine via Vital Signs", 
                "time_frame": "From Baseline until Follow-up"
            }, 
            {
                "measure": "Safety and tolerability of co-administered baclofen and memantine via ECG", 
                "time_frame": "From Baseline until Follow-up"
            }, 
            {
                "measure": "Safety and tolerability of co-administered baclofen and memantine via Clinical Laboratory Tests", 
                "time_frame": "From Baseline until Follow-up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02001584"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via Cmax", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via Tmax", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via AUC", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via MRT", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via CL/F", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via T1/2", 
                "time_frame": "From Baseline until Day 32"
            }, 
            {
                "measure": "Pharmacokinetic parameters of co-administered baclofen and memantine via CLR", 
                "time_frame": "From Baseline until Day 32"
            }
        ], 
        "source": "Gedeon Richter Plc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gedeon Richter Plc.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}